Pneumoconiosis is a lung disease that makes breathing hard and is caused by breathing in dust at work. Pneumoconiosis can be caused by a number of different things that are breathed in. This disease is caused by both organic and inorganic things. The Centers for Disease Control and Prevention say that 260,000 people died from pneumoconiosis in 2013. The market has grown because more people are getting pneumoconiosis, more people are smoking, and air pollution is getting worse. About 75% of the cases of non-asbestos pneumoconiosis that were reported to the IIDB in 2009 were from people over the age of 65. According to the Centers for Disease Control and Prevention, more than 480,000 people die every year in the United States because they smoke cigarettes.

1. Contrive Datum Insights
Global Research And Consulting
A complete solution to explore all the potential aspect to
drive the growth of the business industries.

2. v
ABOUT US
Contrive Datum Insights (CDI) is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers. CDI’s experienced
team of Analysts, Researchers, and Consultants uses proprietary data sources and various
tools and techniques to gather, and analyse information. Our business offerings represent the
latest and the most reliable information indispensable for businesses to sustain a competitive
edge.
Each CDI syndicated research report covers a different sector — such as chemicals, materials,
metals & mining, pharmaceuticals, energy, automotive, food and beverages, semiconductors,
med-devices, consumer goods and information technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider scope and stratified
research methodology, our syndicated reports strive to serve the overall research requirement
of clients.

3. v
Services Offered :
 Market Intelligence & Market Opportunity
Assessment
 Market Size & Segmentation
 Market Entry Strategy
 Competitor Benchmarking
 Pricing Intelligence
 Customer Intelligence
 Sourcing Intelligence
 New-Generation Products & Technologies
 Distribution & Sales Channel Assessment

4. v
CLIENTELE:
Some of the global leading clients that we have served:

5. v
CLIENTELE:
Some of the global leading clients that we have served:

6. v
The pneumoconiosis market is expected to reach USD 2,280.88 million by 2030, with a 9.40% CAGR
during the projection period.Pneumoconiosis is a restrictive lung disease caused by breathing in
dust at work. When breathed, a number of different things can cause pneumoconiosis. Both living
and nonliving things are to blame for this disease. According to the Centers for Disease Control and
Prevention (CDC), 260,000 people died of pneumoconiosis in 2013. Pneumoconiosis is becoming
more common, more people are smoking, and air pollution is getting worse, all of which are driving
the rise of the market. About 75% of the cases of non-asbestos pneumoconiosis reported by the
IIDB scheme in 2009 were in people over 65 years old. According to the Centers for Disease Control
and Prevention, cigarette smoking is the top cause of death in the United States, causing more than
480,000 deaths every year.
Market Overview

7. v
By Region:
The United States has more people with pneumoconiosis than any other country. Aside from this, the
U.S. market is growing because there are more patients, their habits are changing, and they are
spending more on healthcare. According to the Centers for Disease Control and Prevention, about 15
out of every 100 people over 18 in the U.S. smoked in 2015. This means that about 36.5 million
people in the U.S. smoke at the moment. This disease is more likely to happen if there are more
people who smoke. The market is also growing because more people are learning about different
diagnostic methods and new technologies.Asia-Pacific is the biggest market for pneumoconiosis,
followed by Europe. The market will be driven by the number of smokers, the amount of money
available for study, and the government's support for research and development.Asia-Pacific is the
fastest-growing market region because it has a large number of patients, a growing economy, and a
lot of possibilities.

8. v
The Global Pneumoconiosis Market has been segmented into:
By Type:
• Asbestosis
• Berylliosis
• Byssinosis
• Coal Workers Pneumoconiosis
• Silicosis
• Others
Treatment Type
•Mucolytic Agent
•Antibiotic
•Others
•Route of Administration
•Oral
•Inhalation
•Others
End Users
•Hospitals
•Homecare
•Specialty Clinics
•Others

9. v
The Global Pneumoconiosis Market has been segmented into:
By Region
North America
• US
• Canada
• Mexico
• Rest of North America
The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
•Latin America
• Brazil
• Argentina
• Rest of Latin America
By Region
Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
By Region
Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe

10. v
Pneumoconiosis can happen when a person breathes in dust particles such as asbestos, coal dust, or
silica. If these particles get into the lungs' passageways or air sacs, the body will try to fight them off by
making them red and swollen. Since there is no cure for pneumoconiosis yet, treatment works on
managing symptoms and keeping the disease from getting worse. The treatment plan for this disease
includes oxygen therapy, bronchodilators, antibiotics, and a mucolytic agent. Bronchodilators are used
to treat breathing problems, while corticosteroids can help with congestion.The rise in the number of
people who smoke around the world will be a big factor in increasing the growth rate of the market. In
the United States, cigarette smoking is the main cause of preventable disability, disease, and even
death, causing about 480,000 deaths each year. In the United States, nearly 13 out of every 100 people
aged 18 and up (12.5 percent) have smoked cigarettes in 2020. In the United States, this means that
about 30.8 million adults smoke. More than 16 million Americans have a disorder linked to smoking.
Key Market Updates:

11. v
• Novartis
• Abbott
• Eli Lilly
• Sunpharma
• Sanofi
• Novo Nordisk
• others.
MARKET PLAYERS

12. v
Customer Experiences
“Very happy with the service. Report quality as well as response time
for my custom market study was great. I am looking forward to work
with Contrive Datum Insights (CDI) in future. “
G. Luca, A+ Outsourced Marketing
“We are satisfied with research report offered by Contrive Datum
Insights (CDI) .” We appreciate your support throughout the project.”
Consulting Company (privacy requested)
"You and your team did a terrific job on this project.” CDI will be at the
top of our list in the future for market research projects.”
Europe based Fortune 500 Company (privacy requested)

13. v
Benefits of
Association
By associating with Contrive Datum Insights (CDI) , customer can enjoy following
benefits:
 One-Stop-Destination for all research needs (Syndicate and Custom Reports)
 Reduced Budget and Faster Turnaround Time
 Focused Research Team - Contrive Datum Insights (CDI) can arrange a dedicated team of
2-3 resources with 1 Research Manager , who will look after any ad-hoc needs of the client
 Dedicated Account Manager
 24/7 availability for any custom needs of the client
 Flexible Partnering Model to accommodate client’s research needs
 Access to Data-Cuts related to required Market for global region
 ▪ Industry Update on Weekly/Bi-Weekly/Monthly basis
 ▪ Market Trend Analysis on Monthly/Quarterly basis

14. v
To know more about us, please visit our website:
www.contrivedatuminsights.com
For sales queries or new topics email us on:
anna@contrivedatuminsights.com
Thank You!